These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 14253148

  • 1. ACTIVATION OF RABBIT PLASMINOGEN BY STREPTOKINASE.
    CHATTOPADHYAY DP, CLIFFTON EE.
    Am J Physiol; 1965 Jan; 208():190-7. PubMed ID: 14253148
    [No Abstract] [Full Text] [Related]

  • 2. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS.
    TYLER HM, LACK CH.
    Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258
    [No Abstract] [Full Text] [Related]

  • 3. [LEUKOCYTIC FIBRINOLYSIS].
    CAVIEZEL O, VOLLERY M, VANNOTTI A.
    Schweiz Med Wochenschr; 1964 Jul 18; 94():1016-20. PubMed ID: 14243603
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [EFFECT OF FIBRINOLYTIC ACTION FOUND IN ASCITES OF EHRLICH CANCER CELL IN MICE].
    HIRATA T.
    Kobe Ika Daigaku Kiyo; 1963 Dec 18; 25():1-9. PubMed ID: 14117791
    [No Abstract] [Full Text] [Related]

  • 7. MECHANISM OF HUMAN PLASMINOGEN ACTIVATION BY STREPTOKINASE AND HUMAN PLASMIN.
    BLATT WF, GRAY JL, JENSEN H.
    Thromb Diath Haemorrh; 1964 Apr 15; 11():85-93. PubMed ID: 14167118
    [No Abstract] [Full Text] [Related]

  • 8. STUDIES ON THE ADMINISTRATION OF STREPTOKINASE. A METHOD TO OBTAIN THROMBOLYTIC EFFECT WITHOUT EXCESSIVE FIBRINOGENOLYSIS.
    HELLE I, AAS K, GODAL HC.
    Sangre (Barc); 1964 Apr 15; 38():167-74. PubMed ID: 14217607
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. FIBRINOLYSIS AND THE PLASMA PROTEIN ELECTROPHORETIC PATTERN.
    BIELAWIEC M, NILSSON IM.
    Scand J Clin Lab Invest; 1964 Apr 15; 16():513-20. PubMed ID: 14209211
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS].
    MATTIOLI G, RABITTI G, NAVA C.
    Minerva Cardioangiol; 1964 Jan 15; 12():25-8. PubMed ID: 14130219
    [No Abstract] [Full Text] [Related]

  • 16. THE EFFECT OF ATROMID-S ON THE FIBRINOLYTIC ENZYME SYSTEM.
    SWEET B, RIFKIND BM, MCNICOL GP.
    J Atheroscler Res; 1965 Jan 15; 5(3):347-50. PubMed ID: 14290298
    [No Abstract] [Full Text] [Related]

  • 17. SOME PROPERTIES OF THE ANTIFIBRINOLYTICALLY ACTIVE ISOMER OF AMINO-METHYLCYCLOHEXANE CARBOXYLIC ACID.
    DUBBER AH, MCNICOL GP, DOUGLAS AS, MELANDER B.
    Lancet; 1964 Dec 19; 2(7373):1317-9. PubMed ID: 14224037
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.